• About us
• Contact

Advertisement

Organisation › Details

Otsuka (Group)

Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy, "Otsuka-people creating new products for better health worldwide." Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases, and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment. For more information, please visit www.otsuka.co.jp/en. About Otsuka Pharmaceutical Development & Commercialization, Inc. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is involved in conducting all phases of clinical research and development of innovative healthcare products to address unmet medical needs. OPDC is well established in the scientific community as a globally-focused organization that plays a leadership role in the research and development of Otsuka's ethical healthcare products. The company is dedicated to improving the quality of human life and patient health around the world with a strong commitment to research and development in the areas of neuroscience, cardiovascular diseases, and oncology. OPDC is part of the Otsuka Group companies. For more information, visit www.otsuka-us.com. OPDC is a subsidiary of Otsuka America, Inc., which is wholly owned by Otsuka Pharmaceutical Co., Ltd. *

 

	Start	1964-08-10 established
	Industry	pharmaceutical
	Region	Japan_oo
	Country	Japan
	City	101-0048 Tokyo
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2007-03-31)
	Currency	USD
	Annual sales	6,800,000,000 (sales (2005 fiscal))
		* Document for »About Section«:
		Record changed: 2024-08-24

Advertisement

More documents for Otsuka (Group)

• [1] LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.